Author: user

The Hyundai Venue, a subcompact crossover SUV, stands out in the affordable automotive market. Priced competitively at $19,900 for the 2024 model year, it offers a compelling blend of features and value. Despite its lower price point, the Venue doesn’t compromise on personality or performance. Based on the same platform as the fifth generation Accent, it shares its compact size and agile handling. While it may have been introduced in 2019, the Venue’s combination of style, practicality, and affordability continues to make it a compelling choice for budget conscious shoppers. Its stylish exterior, featuring bold lines and modern accents, complements…

Read More

Image source: Getty Images On 23 September, the deputy chairman of Dunelm Group (LSE:DNLM), the FTSE 250 home furnishings retailer, and his wife sold stock in the company worth £114m (4.9%). Due to the large number of shares involved, Sir Will Adderley had to offload them at 1,140p each — a discount of 7.7% to the prevailing market price. Although the family still retains a 32.8% interest, in my opinion, selling such a large slice of the company sends out the wrong message. In fact, it goes against the advice of two brokers who, in September, issued guidance notes to…

Read More

Ford’s recent initiative to boost EV sales involves offering home charging stations to all buyers of its Mustang Mach-E, F-150 Lightning, or E-Transit van. This move is strategically designed to address a major concern among potential EV buyers: the ability to charge their vehicles conveniently and efficiently at home. A study conducted by Mercury Analytics revealed that nearly 90% of respondents were more likely to purchase an EV if they could charge it at home, highlighting the significance of this feature. In addition to the home charging stations, Ford has established a partnership with Tesla, allowing Ford EV owners to…

Read More

FRANKFURT (Reuters) -Germany’s Fresenius said it was checking options to speed up the start of new production lines of medical equipment at a North Carolina facility to help mitigate potential shortages from hurricane damage to rival Baxter (NYSE:)’s site in the same state. “We are working with the U.S. Food and Drug Administration’s Drug Shortage Staff, which is actively engaged with Baxter and other manufacturers” to assess whether and by how much capacity has to be increased, Fresenius said in a statement. The Germany-based healthcare group said its generic hospital drugs unit Fresenius Kabi had recently started manufacturing intravenous (IV)…

Read More

Image source: M&S Group plc The FTSE 100 has a reputation for being a bit of a plodder. Given that it’s up just 30% in 10 years, that’s understandable. However, if we also include reinvested dividends, the total return would be 82% over the same period, according to Vanguard. That’s a much more respectable return. So far in 2024, the index is up around 6.4%, meaning it’s on course (with dividends) to slightly outperform its 8% historical average. But a handful of FTSE 100 shares certainly aren’t following this single-digit return script. Here are two that are up way more…

Read More

CHICAGO, Oct. 9, 2024 /PRNewswire/ — Jones  Lang LaSalle Incorporated (NYSE: JLL) will host a conference call and webcast to discuss third quarter 2024 results on Wednesday, November 6, 2024, at 9 a.m. Eastern time. The conference call can be accessed live over the phone by dialing (888) 660-6392; the conference ID number is 5398158. Listeners are asked to please dial in 10 minutes prior to the call start time and provide the conference ID number to be connected. The conference call will also be webcast live from the company’s Investor Relations website at ir.jll.com. The presentation slides to supplement…

Read More

(Bloomberg) — The rally that’s helped US stocks almost double in value over the past five years is tapering off, and investors should expect low but positive returns on their investments, according to Bill Gross.Most Read from BloombergThe billionaire investor recommends keeping exposure to the stock market at average levels, while focusing portfolios more on defensive stocks with a small position in bonds.“No bear market, but it’s not the same bull market anymore,” Gross, the co-founder and former chief investment officer of Pacific Investment Management Co., wrote in his latest investment outlook.Gross’s comments add to a steady drumbeat of warnings…

Read More

Image source: Getty Images At 8,220 points, the FTSE 100 is less than 200 points away from the all-time highs that were reached earlier this year. Yet as we start the final quarter of the year, there are several reasons being flagged as potential catalysts for a strong push higher through to year-end. Here’s why I think that 9,000 points isn’t unrealistic, as well as a stock that could help the rally. Faster cuts One factor would be faster-than-expected interest rate cuts in November and December from the Bank of England. In an article released last week, Governor Bailey hinted…

Read More

This article summarizes the most significant insider buying and selling activities reported for US stocks on Tuesday, October 8, 2024. Top Insider Buys: • FrontView REIT, Inc. (NYSE:FVR): Alyeska Investment Group, a significant shareholder in FrontView REIT, Inc., has increased its stake in the company. The investment group purchased 810,810 shares worth approximately $15.5 million at an average price of $19.11. The transactions were executed on October 3, 2024, through multiple acquisitions of 135,135 shares each. This substantial investment demonstrates Alyeska’s continued confidence in the real estate investment trust’s future prospects. • Eton Pharmaceuticals , Inc. (NASDAQ:): Opaleye Management Inc.,…

Read More

Interactions with readers since Budget 2024 have made us realise that some investors are unaware of the difference between tax harvesting and portfolio rebalancing. One could also add “profit booking” into the mix. In this article, we explain the difference between these actions.Profit Booking: This is a fallacy. You cannot redeem only profits from the capital markets. You buy at market price and sell at market price. So, any redemption will always have some part principal and some part capital gain.The redeemed amount is pushed to fixed income instruments – savings account (where it waits for a “dip”) or FD…

Read More